T1	Age 25 36	54-year-old
T2	Gender 37 43	female
T3	Activity 48 56	admitted
E1	Activity:T3 
T4	Location 64 72	hospital
#1	AnnotatorNotes T4	Location
T5	Disease_disorder 108 110	HF
E2	Disease_disorder:T5 
#2	AnnotatorNotes E2	Heart failure
T6	Date 138 157	three years earlier
E3	Date:T6 
T7	Disease_disorder 169 171	MI
E4	Disease_disorder:T7 
#3	AnnotatorNotes E4	myocardial infarction
T8	Detail_Description 163 168	acute
R1	MODIFIER Arg1:T8 Arg2:E4	
T9	Diagnostic_procedure 185 205	coronary angiography
E5	Diagnostic_procedure:T9 
T10	Sign_symptom 213 251	occlusion of the right coronary artery
E6	Sign_symptom:T10 
T11	Sign_symptom 257 320	collateral circulation from the left descending coronary artery
E7	Sign_symptom:T11 
T12	Therapeutic_procedure 357 378	coronary intervention
E8	Therapeutic_procedure:T12 
A1	POLARITY E8 NEG
T13	Activity 387 402	hospitalisation
E9	Activity:T13 
T14	Disease_disorder 409 411	MI
E10	Disease_disorder:T14 
T16	Lab 584 623	Nterminal-pro-brain natriuretic peptide
E12	Lab:T16 
T17	Qualitative_concept 566 574	elevated
R2	MODIFIER Arg1:T17 Arg2:E12	
T18	Lab_value 636 647	10581 pg/mL
R3	MODIFIER Arg1:T18 Arg2:E12	
T19	Sign_symptom 650 669	cardiac enlargement
E13	Sign_symptom:T19 
T20	Activity 542 553	examination
E14	Activity:T20 
T21	Lab 688 727	left ventricular end-diastolic diameter
E15	Lab:T21 
T22	Lab_value 736 741	81 mm
R4	MODIFIER Arg1:T22 Arg2:E15	
T23	Qualitative_concept 678 687	increased
R5	MODIFIER Arg1:T23 Arg2:E15	
T24	Lab 748 782	left ventricular ejection fraction
E16	Lab:T24 
T25	Severity 744 747	low
R6	MODIFIER Arg1:T25 Arg2:E16	
T26	Lab_value 790 793	25%
R7	MODIFIER Arg1:T26 Arg2:E16	
T27	Sign_symptom 800 808	akinesis
E17	Sign_symptom:T27 
T28	Anatomical_structure 843 862	inferolateral walls
R8	MODIFIER Arg1:T28 Arg2:E17	
T29	Anatomical_structure 816 824	inferior
T30	Anatomical_structure 826 838	inferoseptal
R9	MODIFIER Arg1:T29 Arg2:E17	
R10	MODIFIER Arg1:T30 Arg2:E17	
T31	Sign_symptom 882 893	hypokinesis
E18	Sign_symptom:T31 
T32	Anatomical_structure 897 930	other walls of the left ventricle
T33	Severity 868 874	severe
T34	Qualitative_concept 875 881	global
R11	MODIFIER Arg1:T34 Arg2:E18	
R12	MODIFIER Arg1:T33 Arg2:E18	
R13	MODIFIER Arg1:T32 Arg2:E18	
T35	Disease_disorder 977 980	CAD
E19	Disease_disorder:T35 
#4	AnnotatorNotes E19	coronary artery disease
T36	Disease_disorder 997 1018	arterial hypertension
E20	Disease_disorder:T36 
T37	Disease_disorder 1020 1041	hypercholesterolaemia
E21	Disease_disorder:T37 
T38	Disease_disorder 1043 1065	ventricular arrhythmia
E22	Disease_disorder:T38 
T39	Medication 1067 1077	carvedilol
E23	Medication:T39 
T40	Medication 1079 1087	ramipril
E24	Medication:T40 
T41	Medication 1089 1103	spironolactone
E25	Medication:T41 
T42	Medication 1105 1115	furosemide
E26	Medication:T42 
T43	Medication 1117 1129	atorvastatin
E27	Medication:T43 
T44	Medication 1131 1144	trimetazidine
E28	Medication:T44 
T45	Medication 1146 1153	aspirin
E29	Medication:T45 
T46	Date 1156 1172	Two months later
E30	Date:T46 
T47	Activity 1185 1194	admission
E31	Activity:T47 
T48	Lab 1241 1245	NYHA
E32	Lab:T48 
T15	Lab_value 457 466	Class III
T49	Lab 484 532	New York Heart Association (NYHA) classification
E11	Lab:T49 
R14	MODIFIER Arg1:T15 Arg2:E11	
T50	Lab 1256 1265	NT-proBNP
E33	Lab:T50 
T51	Lab 1278 1283	LVEDD
E34	Lab:T51 
T52	Lab 1291 1295	LVEF
E35	Lab:T52 
T53	Lab_value 1266 1276	1869 pg/mL
R15	MODIFIER Arg1:T53 Arg2:E33	
T54	Lab_value 1284 1289	73 mm
R16	MODIFIER Arg1:T54 Arg2:E34	
T55	Lab_value 1296 1299	35%
R17	MODIFIER Arg1:T55 Arg2:E35	
T56	Sign_symptom 1337 1345	akinesis
E36	Sign_symptom:T56 
T57	Sign_symptom 1359 1370	hypokinesis
E37	Sign_symptom:T57 
T58	Qualitative_concept 1350 1358	moderate
R18	MODIFIER Arg1:T58 Arg2:E37	
T59	Anatomical_structure 1374 1385	other walls
R19	MODIFIER Arg1:T59 Arg2:E37	
T60	Anatomical_structure 1305 1336	inferior and inferolateral wall
R20	MODIFIER Arg1:T60 Arg2:E36	
T61	Diagnostic_procedure 1388 1421	Cardiovascular magnetic resonance
E38	Diagnostic_procedure:T61 
T62	Lab 1463 1490	late gadolinium enhancement
E39	Lab:T62 
T63	Anatomical_structure 1504 1527	inferoseptal (mid-wall)
T64	Anatomical_structure 1529 1555	inferior (sub-endocardial)
T65	Anatomical_structure 1560 1586	inferolateral (transmural)
R21	MODIFIER Arg1:T63 Arg2:E39	
R22	MODIFIER Arg1:T64 Arg2:E39	
R23	MODIFIER Arg1:T65 Arg2:E39	
T66	History 1605 1635	no history of recent infection
#5	AnnotatorNotes T66	history
T68	Sign_symptom 1662 1675	LV dilatation
E40	Sign_symptom:T68 
T69	Lab 1705 1708	LGE
E41	Lab:T69 
T70	Qualitative_concept 1679 1701	characteristic pattern
R24	MODIFIER Arg1:T70 Arg2:E41	
T71	Disease_disorder 1713 1724	myocarditis
E42	Disease_disorder:T71 
T72	Anatomical_structure 1732 1744	inferoseptal
T73	Anatomical_structure 1749 1763	inferior walls
R25	MODIFIER Arg1:T72 Arg2:E42	
R26	MODIFIER Arg1:T73 Arg2:E42	
T74	Lab 1828 1838	troponin I
E43	Lab:T74 
T75	Quantitative_concept 1840 1851	0.014 ng/mL
R27	MODIFIER Arg1:T75 Arg2:E43	
T76	Qualitative_concept 1793 1824	slightly elevated concentration
R28	MODIFIER Arg1:T76 Arg2:E43	
T77	Diagnostic_procedure 1854 1870	Echocardiography
E44	Diagnostic_procedure:T77 
T78	Sign_symptom 1910 1933	coronary artery changes
E45	Sign_symptom:T78 
T79	Sign_symptom 1938 1959	cardiac contractility
E46	Sign_symptom:T79 
T80	Qualitative_concept 1882 1897	low correlation
R29	MODIFIER Arg1:T80 Arg2:E45	
R30	MODIFIER Arg1:T80 Arg2:E46	
T81	Disease_disorder 2020 2031	myocarditis
E47	Disease_disorder:T81 
T82	Diagnostic_procedure 2070 2091	endomyocardial biopsy
E48	Diagnostic_procedure:T82 
T83	Diagnostic_procedure 2112 2115	EMB
E49	Diagnostic_procedure:T83 
T84	Sign_symptom 2120 2145	not confirm the suspicion
E50	Sign_symptom:T84 
A2	POLARITY E50 NEG
T85	Lab 2166 2172	Dallas
E51	Lab:T85 
T86	Lab 2233 2261	immunohistochemical criteria
E52	Lab:T86 
T87	Lab 2331 2365	Electron microscopy of EMB samples
E53	Lab:T87 
T88	Sign_symptom 2375 2434	ultrastructural changes in all elements of the heart tissue
E54	Sign_symptom:T88 
T89	Sign_symptom 2541 2562	no virus was detected
E55	Sign_symptom:T89 
A3	POLARITY E55 NEG
T90	Therapeutic_procedure 2565 2585	HF and CAD treatment
E56	Therapeutic_procedure:T90 
T91	Qualitative_concept 2603 2668	according to the guidelines of the European Society of Cardiology
R31	MODIFIER Arg1:T91 Arg2:E56	
T92	Anatomical_structure 2436 2446	myofibrils
T93	Anatomical_structure 2448 2455	nucleus
T94	Anatomical_structure 2457 2470	mitochondrion
T95	Anatomical_structure 2472 2493	endoplasmic reticulum
T96	Anatomical_structure 2495 2519	intercellular connection
T97	Anatomical_structure 2521 2534	blood vessels
R32	MODIFIER Arg1:T92 Arg2:E54	
R33	MODIFIER Arg1:T93 Arg2:E54	
R34	MODIFIER Arg1:T94 Arg2:E54	
R35	MODIFIER Arg1:T95 Arg2:E54	
R36	MODIFIER Arg1:T96 Arg2:E54	
R37	MODIFIER Arg1:T97 Arg2:E54	
T98	Date 2679 2697	three months later
E57	Date:T98 
T99	Activity 2714 2728	rehospitalised
E58	Activity:T99 
T100	Disease_disorder 2740 2755	HF exacerbation
E59	Disease_disorder:T100 
T101	Lab_value 1246 1254	class II
R38	MODIFIER Arg1:T101 Arg2:E32	
T102	Lab 2757 2761	NYHA
E60	Lab:T102 
T103	Lab_value 2762 2771	Class III
R39	MODIFIER Arg1:T103 Arg2:E60	
T104	Lab 2773 2782	NT-proBNP
E61	Lab:T104 
T105	Lab_value 2783 2793	1980 pg/dL
T106	Lab 2795 2803	troponin
E62	Lab:T106 
T107	Quantitative_concept 2804 2811	3 ng/mL
T108	Lab 2813 2818	LVEDD
E63	Lab:T108 
T109	Quantitative_concept 2819 2824	77 mm
T110	Lab 2826 2830	LVEF
E64	Lab:T110 
T111	Quantitative_concept 2831 2834	30%
T112	Quantitative_concept 2836 2840	8048
T113	Sign_symptom 2841 2866	ventricular extrasystoles
E65	Sign_symptom:T113 
T114	Quantitative_concept 2867 2888	without complex forms
R40	MODIFIER Arg1:T114 Arg2:E65	
T115	Diagnostic_procedure 2900 2921	Holter ECG monitoring
E66	Diagnostic_procedure:T115 
T116	Duration 2892 2899	24-hour
E67	Duration:T116 
R41	MODIFIER Arg1:E67 Arg2:E66	
R42	MODIFIER Arg1:T112 Arg2:E65	
T117	Diagnostic_procedure 2939 2959	coronary angiography
E68	Diagnostic_procedure:T117 
T118	Result_outcome 2960 3012	resembled these observed in the previous examination
R43	MODIFIER Arg1:T118 Arg2:E68	
T119	Lab 3085 3132	real-time polymerase chain reaction examination
E69	Lab:T119 
T120	Qualitative_concept 3154 3232	to detect viral nucleic acids in the samples collected during the previous EMB
R44	MODIFIER Arg1:T120 Arg2:E69	
T121	Lab 3271 3275	qPCR
E70	Lab:T121 
T122	Lab_value 3289 3308	presence of HEV RNA
R45	MODIFIER Arg1:T122 Arg2:E70	
T123	Disease_disorder 3314 3334	viral cardiomyopathy
E71	Disease_disorder:T123 
T124	Medication 3395 3407	interferon-β
E72	Medication:T124 
T125	Dosage 3458 3475	62.5 μg (0.25 mL)
T126	Quantitative_concept 3467 3474	0.25 mL
T127	Duration 3476 3493	in the first week
E73	Duration:T127 
T128	Dosage 3495 3510	125 μg (0.5 mL)
T129	Quantitative_concept 3503 3509	0.5 mL
T130	Duration 3511 3540	in the second and third weeks
E74	Duration:T130 
T131	Dosage 3546 3564	187.5 μg (0.75 mL)
T132	Quantitative_concept 3556 3563	0.75 mL
T133	Administration 3565 3579	subcutaneously
T134	Frequency 3580 3595	every other day
E75	Frequency:T134 
T135	Duration 3596 3637	from the fourth to the twenty-fourth week
E76	Duration:T135 
T136	Duration 3641 3677	In the fourth month of the treatment
E77	Duration:T136 
T137	Diagnostic_procedure 3679 3682	EMB
E78	Diagnostic_procedure:T137 
T138	Result_outcome 3701 3724	no HEV RNA was detected
R46	MODIFIER Arg1:T138 Arg2:E78	
T139	Date 3754 3783	After six months of treatment
E79	Date:T139 
T140	Medication 3789 3801	interferon-β
E80	Medication:T140 
T141	Lab 3843 3847	NYHA
E81	Lab:T141 
T142	Lab_value 3848 3855	class I
T143	Lab 3857 3866	NT-proBNP
E82	Lab:T143 
T144	Lab_value 3867 3876	512 pg/mL
T145	Lab 3878 3883	LVEDD
E83	Lab:T145 
T146	Lab_value 3884 3889	68 mm
T147	Lab 3891 3895	LVEF
E84	Lab:T147 
T148	Lab_value 3896 3899	45%
T149	Sign_symptom 3929 3932	ExV
E85	Sign_symptom:T149 
#7	AnnotatorNotes E85	ventricular extrasystoles
T150	Diagnostic_procedure 3944 3960	Holter recording
E86	Diagnostic_procedure:T150 
T151	Duration 3936 3943	24-hour
E87	Duration:T151 
T152	Quantitative_concept 3980 3988	1889 ExV
T153	Qualitative_concept 3990 4011	without complex forms
T154	Sign_symptom 4014 4039	No adverse drug reactions
E88	Sign_symptom:T154 
A4	POLARITY E88 NEG
T155	Date 4054 4062	two-year
E89	Date:T155 
T156	Activity 4063 4072	follow-up
E90	Activity:T156 
T157	Qualitative_concept 4077 4087	uneventful
R47	MODIFIER Arg1:T157 Arg2:E90	
R48	MODIFIER Arg1:E89 Arg2:E90	
R49	MODIFIER Arg1:T142 Arg2:E81	
R50	MODIFIER Arg1:T144 Arg2:E82	
R51	MODIFIER Arg1:T146 Arg2:E83	
R52	MODIFIER Arg1:T148 Arg2:E84	
*	OVERLAP E1 E2
R53	AFTER Arg1:E2 Arg2:E4	
*	OVERLAP E4 E5 E6 E7 E8 E9 E10 E11 E14 E12 E13 E15 E16 E17 E18
T158	Therapeutic_procedure 965 972	treated
E91	Therapeutic_procedure:T158 
R54	BEFORE Arg1:E18 Arg2:E91	
*	OVERLAP E91 E19 E20 E21 E22 E23 E24 E25 E26 E27 E28 E29
R55	BEFORE Arg1:E29 Arg2:E31	
R56	MODIFIER Arg1:E30 Arg2:E31	
*	OVERLAP E31 E32 E33 E34 E35 E36 E37 E38 E39 E40 E41 E42 E43 E44 E45 E46 E47 E48 E49 E50 E51 E52 E53 E54 E55 E56
A5	POLARITY E47 MAYBE_POS
R57	BEFORE Arg1:E56 Arg2:E58	
R58	MODIFIER Arg1:E57 Arg2:E58	
*	OVERLAP E58 E59 E60 E61 E62 E63 E64 E65 E66 E68 E69 E70 E71 E72
R59	MODIFIER Arg1:T125 Arg2:E72	
R60	MODIFIER Arg1:T126 Arg2:E72	
R61	MODIFIER Arg1:E73 Arg2:T125	
R62	MODIFIER Arg1:T128 Arg2:E72	
R63	MODIFIER Arg1:T129 Arg2:E72	
R64	MODIFIER Arg1:E74 Arg2:T128	
R65	MODIFIER Arg1:T131 Arg2:E72	
R66	MODIFIER Arg1:T132 Arg2:E72	
R67	MODIFIER Arg1:T133 Arg2:T131	
R68	MODIFIER Arg1:E75 Arg2:T131	
R69	BEFORE Arg1:E72 Arg2:E78	
R70	MODIFIER Arg1:E77 Arg2:E78	
R71	MODIFIER Arg1:E76 Arg2:T131	
R72	BEFORE Arg1:E78 Arg2:E80	
R73	MODIFIER Arg1:E79 Arg2:E80	
*	OVERLAP E80 E81 E82 E83 E84 E85 E86 E88
R74	MODIFIER Arg1:E87 Arg2:E86	
R75	MODIFIER Arg1:T152 Arg2:E85	
R76	MODIFIER Arg1:T153 Arg2:E85	
R77	BEFORE Arg1:E88 Arg2:E90	
R78	MODIFY Arg1:T4 Arg2:E1	
T67	Sign_symptom 1639 1644	fever
E92	Sign_symptom:T67 
A6	POLARITY E92 NEG
T159	Anatomical_structure 230 251	right coronary artery
T160	Anatomical_structure 289 320	left descending coronary artery
T161	Severity 207 212	total
R79	MODIFY Arg1:T161 Arg2:E6	
T162	Anatomical_structure 1587 1592	walls
R80	MODIFY Arg1:T105 Arg2:E61	
R81	MODIFY Arg1:T107 Arg2:E62	
R82	MODIFY Arg1:T109 Arg2:E63	
R83	MODIFY Arg1:T111 Arg2:E64	
T163	Location 1202 1210	hospital
R84	MODIFY Arg1:T163 Arg2:E31	
